AbbVie's (NYSE:ABBV) Q4 CY2025: Beats On Revenue [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Its non-GAAP profit of $2.71 per share was 2.2% above analysts' consensus estimates. Is now the time to buy AbbVie? Find out in our full research report Revenue: $16.62 billion vs analyst estimates of $16.25 billion (10% year-on-year growth, 2.3% beat) Adjusted EPS: $2.71 vs analyst estimates of $2.65 (2.2% beat) Adjusted EPS guidance for the upcoming financial year 2026 is $14.47 at the midpoint, beating analyst estimates by 1.7% Operating Margin: 27.3%, up from -9.9% in the same quarter last year Constant Currency Revenue rose 9.5% year on year (6.1% in the same quarter last year) Market Capitalization: $398.8 billion "2025 was another outstanding year for AbbVie. We delivered record net sales in just the second full year following the U.S. Humira loss of exclusivity, underscoring the strength of our diversified growth platform. We also advanced promising new treatments for patients while enhancing the breadth and depth of our pipeline with strategic investments," sa
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- ?????????????????????????????????????2035????38???????????????????????????(CAGR)?6.11%?????????? [CNET News]CNET News
- Check Your CGM: Recalled FreeStyle Libre 3 Sensors Associated With 7 Deaths [CNET News]CNET News
- Do Wall Street Analysts Like Abbott Laboratories Stock? [Yahoo! Finance]Yahoo! Finance
- Medtronic set to acquire CathWorks for $585m [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Faces Profit Headwinds as Pediatric Nutrition Remains Under Pressure [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 1/26/26 - Form 4
- 1/22/26 - Form 8-K
- 1/5/26 - Form 4
- ABT's page on the SEC website